NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30183% above fair value
$4.82−0.77 (-13.77%)
Close on Nov 18, 2026Market cap $58.59MP/E –Yield –
NutriBand free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
NutriBand's free cash flow for the twelve months ending Jan 31, 2026 was -$5.14M. For fiscal 2026 it was -$5.14M. The highest annual figure on record is -$1.11M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -$5.14M | – |
| FY2025 | Jan 31, 2025 | -$4.72M | – |
| FY2024 | Jan 31, 2024 | -$3.58M | – |
| FY2023 | Jan 31, 2023 | -$3.07M | – |
| FY2022 | Jan 31, 2022 | -$2.89M | – |
| FY2019 | Jan 31, 2019 | -$1.11M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -$731.83K | – |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -$1.75M | – |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -$1.31M | – |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -$1.34M | – |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -$1.24M | – |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -$1.06M | – |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -$1.58M | – |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -$840.12K | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -$767.38K | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$1.06M | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$995.14K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$752.49K | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$824.03K | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$521.72K | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$932.70K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$788.06K | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$1.26M | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$318.19K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$282.89K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$439.63K | – |
See a number that looks wrong?